Alemtuzumab (Lemtrada)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alemtuzumab (Lemtrada), covering 2009-11-25 to 2009-11-25. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies